Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M143Revenue $M0.1Net Margin (%)0Z-Score6.6
Enterprise Value $M107EPS $-0.1Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %-2.3Quick Ratio21.1Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-2.5Current Ratio21.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-62.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-87.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M178ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with RNN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RNNKen Fisher 2014-09-30 Sold Out $0.662 - $0.875
($0.75)
$ 0.87%Sold Out0
RNNKen Fisher 2014-06-30 Buy $0.79 - $1.28
($0.95)
$ 0.8-16%New holding, 10000 sh.10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RNN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RNN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ahn Chang HoDirector 2015-01-12Sell314,656$0.91-12.09view
Jeong Tae HeumCFO 2015-01-12Sell317,272$0.91-12.09view
Ahn Chang HoDirector 2014-06-12Sell136,193$0.99-19.19view
Jeong Tae HeumCFO 2013-09-09Sell71,139$0.4673.91view
Kivel RichardDirector 2011-10-03Buy2,500$1.04-23.08view
Brandt Peter C.Director 2011-09-09Buy125,000$1.17-31.62view
Brandt Peter C.Director 2011-09-07Buy25,000$0.96-16.67view
Ahn Chang HoChairman & CEO, 10% Owner 2011-05-18Buy1,008,078$1.31-38.93view
Ahn Chang HoChairman & CEO, 10% Owner 2011-04-01Buy320,846$1.22-34.43view
McIntosh David MDirector 2009-07-30Buy5,600$0.80view

Press Releases about RNN :

    Quarterly/Annual Reports about RNN:

    News about RNN:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: RNN, IIG, FSC, GEO, DAN May 21 2011 
    Weekly CEO Buys Highlight: GBDC, EXL, RNN, KYN, CMTL Apr 09 2011 

    More From Other Websites
    Rexahn Pharmaceuticals to Present at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum... Feb 18 2015
    Rexahn Pharmaceuticals to Present at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum... Feb 18 2015
    Rexahn Pharmaceuticals Announces the Publication of Preclinical Data for Supinoxin(TM) (RX-5902)... Feb 09 2015
    Rexahn Pharmaceuticals Announces the Publication of Preclinical Data for Supinoxin(TM) (RX-5902)... Feb 09 2015
    REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Feb 04 2015
    Rexahn Pharmaceuticals Announces the Appointment of Ely Benaim, M.D., as Chief Medical Officer Feb 04 2015
    Rexahn Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference Feb 02 2015
    Rexahn Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference Feb 02 2015
    Rexahn Pharmaceuticals to Present at Biotech Showcase(TM) 2015 Jan 07 2015
    Rexahn Pharmaceuticals to Present at Biotech Showcase(TM) 2015 Jan 07 2015
    Rexahn Pharmaceuticals Announces Publication of Preclinical Data for RX-3117 Demonstrating... Jan 06 2015
    Rexahn Pharmaceuticals Announces Publication of Preclinical Data for RX-3117 Demonstrating... Jan 06 2015
    Why Rexahn Pharmaceuticals (RNN) Could Be Positioned for a Surge? Dec 10 2014
    Rexahn Pharmaceuticals, Inc. (RNN) Rises: Stock Up 8.6% Dec 09 2014
    Rexahn Pharmaceuticals (RNN): Strong Industry, Solid Earnings Estimate Revisions Dec 05 2014
    Rexahn Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 10, 2014 Dec 04 2014
    Rexahn Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 10, 2014 Dec 04 2014
    REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Dec 03 2014
    Print Dec 03 2014
    Rexahn Pharmaceuticals Appoints Richard Rodgers to Its Board of Directors Dec 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK